PrimoGAIA
PrimoGaia opens up a new pathway in Magnetic Resonance Imaging (MRI) by initiating the concept of in vivo “enzymatic imaging” for a better understanding of human physiology, early detection and prognosis of diseases, monitoring of therapeutic treatment.
The project
| 7 partners 4 countries H2020 FET Open |
Start: 01-12-2019 end: 31-05-2023 |
News
#magnetic resonance imaging (MRI), #dynamic nuclear polarization (DNP), #overhauser MRI (OMRI), #enzyme activity, #ultra-low field, #contrast agents, #inflammatory diseases, #enzymatic mapping, #cost efficient sytems, #medical engineering
Chemistry – A European Journal: Highly Sensitive “Off/On” EPR Probes to Monitor Enzymatic Activity
Published in Chemistry Europe
...
PrimoGAIA 2nd Review meeting
The 2nd PrimoGAIA Project Review meeting was successfully held on 26th January 2022.
...
Nanoscale journal: Functionalized silica nanoplatform as a bimodal contrast agent for MRI and optical imaging
Published in the Nanoscale journal
...
Journal of Magnetic Resonance: Enzymatic activity monitoring through dynamic nuclear polarization in Earth magnetic field
Published in the Journal of Magnetic Resonance
...
